Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.72905 | 88 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.71586 | 87 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.7193 | 87 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.72624 | 86 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.39627 | 85 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.67213 | 88 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.82273 | 89 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.15498 | 90 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.60408 | 87 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.7132 | 87 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.65496 | 87 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.70359 | 87 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.82032 | 88 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.23677 | 84 |